MarketReportsOnline.com adds Global
Intravenous (I.V.) Iron Drugs Market Report: 2015 Edition industry research report
of 54 pages published in June 2015 to the Pharmaceuticals market data
collection of its online business intelligence library.
Iron
deficiency anemia is the most common form of anemia throughout the world. It is
estimated that two billion people suffer from iron deficiency anemia worldwide.
To address iron deficiency, iron therapy is important being the critical factor
in the production of red blood cells. Around 4.5 million Americans are
diagnosed and suffering from iron deficiency anemia (IDA).
Generally,
daily oral iron is the first line therapy for most IDA patient but for many
patients oral iron therapy fails as a consequence of compliance, efficacy and
side effects like constipation and gastro intestinal disorders. When oral
supplements fail to meet the requirement, intravenous (I.V.) iron therapy is
used, in which iron is directly injected with a needle into a vein.
Iron given
intravenously allows larger amounts of iron to be provided to patients while
avoiding many of the side effects and treatment compliance issues associated
with oral iron, and can result in faster rises in hemoglobin levels. In the US,
a small fraction of non-dialysis CKD patients who are diagnosed with IDA are
currently being treated with I.V. iron, and thus a significant opportunity is
there for the market.
The key
factors driving growth of the global I.V. iron industry include iron deficiency
in hemodialysis patient cases, growing number of ERSD patients, prevalence of
iron deficiency in women, increasing global healthcare expenditure, increasing
global ageing population and large potential in new therapeutic areas. Some of
the noteworthy trends and developments of this industry are penetration of I.V.
iron in obstetrics and gynecology area, new product development and increase in
awareness of disease. However, the growth of this sector is hindered by
potential risks of using I.V. iron, emerging anemia management therapies and
strict regulatory structures.
Order a copy of “Intravenous (I.V.)
Iron Drugs Market” research report at USD 800 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=411242.
The report
provides a comprehensive study of iron product market and I.V. iron market
globally. It also provides detailed information for key regional markets of I.V
iron industry. The competition in the global I.V. iron market is stiff among
large players like Galenica Group, AMAG Pharmaceuticals Inc. and Actavis Plc.
All these companies have been profiled in the present report highlighting their
key financials and business strategies for growth.
Major points from Table of Contents
are listed below:
1. Overview
2. Market Analysis
3. Market Dynamics
4. Competitive Landscape
5. Company Profiles
6. Market Outlook
List of Tables
Risk Factors for CKD
Emerging Non-Intravenous Therapies
for Anemia Management
I.V. Iron Product
Comparison
Dependent & Independent
Variables (2010-2014)
Correlation Matrix
Model Summary – Coefficient
of Determination
Regression Coefficients
Output
Other Related Reports on Pharmaceuticals Market:
Global Hemophilia Market Report: 2015 Edition (http://www.marketreportsonline.com/409838.html) Hemophilia is an inherited or acquired bleeding
disorder that prevents blood from clotting. People with hemophilia lack, either
partially or completely, an essential clotting factor needed to form stable
blood clots. People with hemophilia do not bleed any faster than normal, but
they can bleed for a longer time.
US Pharmacy Benefit Management (PBM) Industry Report:
2014 Edition (http://www.marketreportsonline.com/395328.html) The PBM providers control drug spending and utilization
by virtue of their advanced tools and techniques, encouraging use of generics
and other lower-cost medications. In the US, there are some independent PBM’s
while some are owned by managed care organizations and retail pharmacies.
Today, the PBM industry has become more determined through a series of mergers
and acquisitions.
About Us:
MarketReportsOnline
comprises of an online library of 2,50,000 reports and in-depth market research
studies of over 5000+ micro markets. We provide 24/7 online and offline support
to our customers. Get in touch with us for your needs of market research
reports.
Contact Us:
Ritesh Tiwari
Corporate Office
TX, Dallas North - Dominion
Plaza,
17304, Preston Road,
Suite 800, Dallas 75252.
Tel: + 1 888 391 5441
E-mail: sales@marketreportsonline.com 
No comments:
Post a Comment